directorate of rational drug use dg of pharmaceutical service & medical devices ministry of...
DESCRIPTION
POLICY PROTECT THE COMMUNITY FROM DISADVANTAGE AND HAZARDS OF SUBSTANDARD PRODUCTS CLINICAL PROVEN TRADITIONAL MEDICINES NEED TO BE DEVELOPED AND TO BE UTILIZED IN MEDICAL CARE FOR COMMNUNITY MoH DECREE No: 47/MENKES/SK/II/1983TRANSCRIPT
DIRECTORATE OF RATIONAL DRUG USEDG OF PHARMACEUTICAL SERVICE & MEDICAL DEVICES
MINISTRY OF HEALTH, INDONESIA
NATIONAL POLICYNATIONAL POLICY
TRADITIONAL MEDICINES IS TRADITIONAL MEDICINES IS AN INTEGRAL PART OF HEALTH CARE AN INTEGRAL PART OF HEALTH CARE
ENSURING ITS SAFETY, EFFICACY & QUALITYENSURING ITS SAFETY, EFFICACY & QUALITY
SUPPORT FURTHER DEVELOPMENT AND IMPROVEMENT OF FORMS OF SUPPORT FURTHER DEVELOPMENT AND IMPROVEMENT OF FORMS OF TRADITIONAL MED. TRADITIONAL MED.
DEEMED SAFE & EFFICACIOUS DEEMED SAFE & EFFICACIOUS IN ORDER TO FULFIL THE GOAL OF IN ORDER TO FULFIL THE GOAL OF
OPTIMAL HEALTH FOR THE COMMUNITYOPTIMAL HEALTH FOR THE COMMUNITY
MoH DECREE No: 47/MENKES/SK/II/1983MoH DECREE No: 47/MENKES/SK/II/1983
POLICY PROTECT THE COMMUNITY FROM DISADVANTAGE AND HAZARDS OF SUBSTANDARD PRODUCTS
CLINICAL PROVEN TRADITIONAL MEDICINES NEED TO BE DEVELOPED AND TO BE UTILIZED IN MEDICAL CARE FOR COMMNUNITY
MoH DECREE No: 47/MENKES/SK/II/1983MoH DECREE No: 47/MENKES/SK/II/1983
WHO
ENCOURAGES AND SUPPORTSTHE INTEGRATION OF TRADITIONAL AND COMPLEMENTARYMEDICINE INTO NATIONAL HEALTH CARE SYSTEMAND TO ENSURETHEIR RATIONAL USE
(LEGAL STATUS OF TCM, WHO 2001)
TRADITIONAL MEDICINES should comply
SAFE
EFECTIVE
QUALITY
RATIONAL USE
(WHO) (WHO) LEGAL STATUS OF TRADITIONAL MEDICINE LEGAL STATUS OF TRADITIONAL MEDICINE AND COMPLEMENTARY/ ALTERNATIVE MEDICINE, 2002AND COMPLEMENTARY/ ALTERNATIVE MEDICINE, 2002
CLASSIFICATION
JAMU (HERBAL MEDICINES)
EKSTRAK TERSTANDAR (STANDARIZED EXTRACT)
FITOFARMAKA (PHYTOPHARMACY)
TOXYCITY TEST ACUTE (LD50)
SUBACUTE
CHRONIC
MUTAGENICITY
TERATOGENICITY
EMBRIOTOXICITY
CARSINOGENICITY
CLINICAL TEST (RCT) (MoH Decree No: 56 / 2000)
TM
SAFEEFECTIVEQUALITY
GMP-TM
(Good Manufacturing Practice – Traditional Medicines) MoH Decree No: 659 / 1991
(KEPMENKES No: 650 Th 1991)
STEPS FOR DEVELOPMENTSTEP I:STEP I:
PRE-CLINICAL TESTPRE-CLINICAL TEST
TOXYICITY TESTTOXYICITY TEST PHARMACODYNAMICAL TESTPHARMACODYNAMICAL TEST
SAFETYSAFETY EFFICACYEFFICACY
SAFETY
TOXYCITYTOXYCITY:
GENERALGENERALTOXYCITYTOXYCITY
SPECIFICSPECIFICTOXYCITY TOXYCITY
ACUTE (LD50)ACUTE (LD50)SUB-ACUTESUB-ACUTE
CHRONICCHRONIC
TERATOGENICTERATOGENICMUTAGENICMUTAGENIC
CARCINOGENICCARCINOGENIC
STEP II
INITIAL STANDARDIZATIONINITIAL STANDARDIZATION
STEP IIISTEP III
PHARMACEUTICAL TECHNOLOGY PHARMACEUTICAL TECHNOLOGY WHICH DEFINE IDENTITY ACURATELYWHICH DEFINE IDENTITY ACURATELY
TO STANDARIZED PRODUCTTO STANDARIZED PRODUCT
STEP IVEFFICACY: EFFICACY:
CLINICAL TEST CLINICAL TEST ACCORDING TO ACCORDING TO GCPGCP
(GOOD CLINICAL PRACTICES)(GOOD CLINICAL PRACTICES)
RANDOMIZEDRANDOMIZED DOUBLE BLIND CONTROLDOUBLE BLIND CONTROL
CLINICAL TESTRESULTSRESULTS
AS A CONDITION FOR REGISTRATION AS A CONDITION FOR REGISTRATION FURTHER UTILIZATION IN FORMAL HEALTH FURTHER UTILIZATION IN FORMAL HEALTH
CARE EFFORTSCARE EFFORTS
KEPMENKES No: 56/MENKES/SK/I/2000
PHYTOPHARMACY
TRADITIONAL MEDICINES WHICH HAVE BEEN PROVEN
SAFE, EFECTIVE QUALITY
STANDARDIZED
MoH Decree No: 760 / 1992
PHYTOPHARMACY
EQUAL TO MODERN MEDICINES
ABLE TO PRESCRIBED BY PHYCISIANS
ABLE TO UTILIZED IN A FORMAL HEALTH CARE FACILITIES
PHYTOPHARMACY
TENSIGARDPHYTODIAR
RHEUMANEERX GRA
STIMUNO
SP3TCENTRE OF
DEVELOPMENT & APPLICATION TRADITIONAL MEDICINES
PERFORM CLINICAL TESTING POTENTIAL ADVANCED TO
PHYTOPHARMACY
(MoH Decree No. 0584/MENKES/SK/VI/1995)
TRADITIONAL MEDICINES
PROHIBITED
MIXED/COMPOUNDED WITH MODERN MEDICINES
MoH Decree 246/Menkes/Per/V/1990MoH Decree 246/Menkes/Per/V/1990
MoH Decree No 1147/D/SK/IV/81 23 JUNE 1977
PROHIBIT PROCUCTION & DISTRIBUTION SUPOSITORIA, INTRAVAGINAL & EYE DROPS OF TM
GUIDELINE OF TRADITIONAL MEDICINES 1985 LABELLING TM
1993 REGULATION TM
MoH Decree No 1516/A/81, 15 MAY 1981TM CONTAIN ETANOL
MEDICATION WITH TM
SHORT TERMSAFETY PROVEN
LONG TERMSAFETY & EFICACY PROVEN
DEVELOPMENT STRATEGYDATA COLLECTION
DEVELOP MEDICATION GUIDELINES
DEVELOP PILOT PROJECT
MONITORING & EVALUATION
DEVELOP TO PHYTOPHARMACY
NOT YET PROVEN IN SAFETY AND EFICACY
ABLE TO UTILIZED OUTSIDE FORMAL MEDICAL CARE
BY MEDICAL STAFF
FOR RESEARCH PURPOSE
COMPLY WITH GOOD CLINICAL PRACTICE (GCP)
TM
TM